Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solventum (SOLV) Net Income (2023 - 2025)

Solventum's Net Income history spans 3 years, with the latest figure at $63.0 million for Q4 2025.

  • For Q4 2025, Net Income rose 110.0% year-over-year to $63.0 million; the TTM value through Dec 2025 reached $1.6 billion, up 225.52%, while the annual FY2025 figure was $1.6 billion, 225.52% up from the prior year.
  • Net Income reached $63.0 million in Q4 2025 per SOLV's latest filing, down from $1.3 billion in the prior quarter.
  • In the past five years, Net Income ranged from a high of $1.3 billion in Q3 2025 to a low of $30.0 million in Q4 2024.
  • Average Net Income over 3 years is $281.7 million, with a median of $187.0 million recorded in 2024.
  • Peak YoY movement for Net Income: plummeted 88.97% in 2024, then skyrocketed 937.7% in 2025.
  • A 3-year view of Net Income shows it stood at $272.0 million in 2023, then tumbled by 88.97% to $30.0 million in 2024, then surged by 110.0% to $63.0 million in 2025.
  • Per Business Quant, the three most recent readings for SOLV's Net Income are $63.0 million (Q4 2025), $1.3 billion (Q3 2025), and $90.0 million (Q2 2025).